Selected novel 5'-amino-2'-hydroxy-1, 3-diaryl-2-propen-1-ones arrest cell cycle of HCT-116 in G0/G1 phase

Authors

  • Lalitha Simon Department of Chemistry, Manipal Institute of Technology, Manipal University, Manipal, 576 104, India
  • K. K. Srinivasan Department of Chemistry, Shri Madhwa Vadiraja Institute of Technology & Management, (affiliated to Visvesvaraya Technological University, Belgaum), Bantakal, Udupi, 574115, India
  • Nitesh Kumar Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, 576 104, India
  • Neetinkumar D. Reddy Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, 576 104, India
  • Subhankar Biswas Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, 576 104, India
  • C. Mallikarjuna Rao Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, 576 104, India
  • Sudheer Moorkoth Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal University, 576 104, India

DOI:

https://doi.org/10.17179/excli2015-610

Keywords:

5'-amino-2'-hydroxy-1,3-diaryl-2-propen-1-ones, cytotoxicity, MTT, acridine orange-ethidium bromide nuclear staining, flow cytometry

Abstract

A series of 5'-amino-2'-hydroxy-1,3-diaryl-2-propen-1-ones (AC1-AC15) were synthesized by Claisen-Schmidt condensation of 5'-acetamido-2'-hydroxy acetophenone with various substituted aromatic aldehydes. The synthesized compounds were characterized by FTIR, 1H NMR and mass spectrometry and evaluated for their selective cytotoxicity using MTT assay on two cancer cell lines namely breast cancer cell line (MCF-7), colon cancer cell line (HCT-116) and one normal kidney epithelial cell line (Vero). Among the tested compounds, AC-10 showed maximum cytotoxic effect on MCF-7 cell line with IC50 value 74.7 ± 3.5 µM. On HCT-116 cells, AC-13 exhibited maximum cytotoxicity with IC50 value 42.1 ± 4.0 µM followed by AC-14 and AC-10 with IC50 values 62 ± 2.3 µM and 95.4 ± 1.7 µM respectively. All tested compounds were found to be safe on Vero cell line with IC50 value more than 200 µM. Based on their highest efficacy on HCT-116, AC-10, AC-13 and AC-14 were selected for mechanistic study on this cell line by evaluating changes nucleomorphological characteristics using acridine orange-ethidium bromide (AOEB) dual stain and by analyzing cell cycle with flow cytometry using propidium iodide stain. In AOEB staining, all three tested compounds showed significant (p < 0.05) increase in percentage apoptotic nuclei compared to control cells, with highest increase in apoptotic nuclei by AC-13 treatment (31 %). Flow cytometric studies showed cell cycle arrest by AC-10 and AC-14 treatment in G0/G1 phase and by AC-13 in G0/G1 and G2/M phase. The study reflected the potential of AC-10, AC-13 and AC-14 to be the lead molecules for further optimization.

Downloads

Published

2016-01-13

How to Cite

Simon, L., Srinivasan, K. K., Kumar, N., Reddy, N. D., Biswas, S., Rao, C. M., & Moorkoth, S. (2016). Selected novel 5’-amino-2’-hydroxy-1, 3-diaryl-2-propen-1-ones arrest cell cycle of HCT-116 in G0/G1 phase. EXCLI Journal, 15, 21–32. https://doi.org/10.17179/excli2015-610

Issue

Vol. 15 (2016)

Section

Original articles

License

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).

Most read articles by the same author(s)